ABOUT US
Board of directorsHans T. Schambye
Christian Hansen
Florian Schönharting
Torsten Goesch
Wyle Solomon
Management
Scientific advisors
Investors
Hans T. Schambye, MD, PhD
Chairman
Hans Schambye joined ReceptIcon in 2006 as Chief Executive Officer. Read more.
Christian Hansen, PhD, MBA
Board member
Christian Hansen is co-founder and partner of Nordic Biotech. Read more.
Florian Schönharting, MSc
Board member
Florian Schönharting is co-founder and partner of Nordic Biotech. Mr. Schönharting is a leading investor in the sector with more than 14 years of investment experience in the biotechnology and healthcare industry.
Mr. Schönharting's previous experience comes primarily from a 10-year tenure at BankInvest Asset Management, a Danish private & public equity group, as managing director and in charge of Biotech investments. During his tenure, Mr. Schönharting was directly responsible for 20+ investments ranging from seed to late stage, resulting in 10+ IPOs or trade sales, including Biomarin Inc., Bavarian Nordic Research Institute, Pharmexa, Pyrosequencing, Glyko Biomedical and Profound Pharma A/S (Maxygen Inc.). Mr. Schönharting was also the initiator, architect and founder of Genmab A/S. In addition he was responsible for seedfunding Zealand Pharma A/S and 7TM Pharma A/S.
Mr. Schönharting received a master's degree in business economics (finance) from the Copenhagen Business School, and was given the McKinsey & Co award for best-of-year student.
Florian Schönharting is currently member of the Board of Directors of the Danish Venture Capital Association (DVCA) and the Danish Corporate Governance Association (DCGA).
Torsten Goesch, MD, PhD, MBA
Board member
Dr. Goesch is a director of BioScience Managers Limited (BML) which he joined in July 2002. Read more.
Wyle Solomon , MSc, MBA
Board member
Wyle Solomon is Vice President at Nordic Biotech. He came to Nordic Biotech in June 2007. Read more.
